Radical Prostatectomy as a First-Line Treatment in Patients with Initial PSA  >20 ng/mL

Table 6

Kaplan-Meier survival analysis, log-rank test: comparison between patients with initial PSA ≤20 ng/mL versus patients with PSA ≤20 ng/mL in four patient groups (patients treated by RP only versus RP plus ART versus RP plus ADT versus RP plus ART plus ADT) with regard to BCR-free, OS, and CSS rates.

Patient group	P value
	BCR-free survival	Overall survival	Cancer-specific survival
RP	0.002	0.501	0.155
RP + ART	0.034	0.315	0.101
RP + ADT	0.008	0.312	0.206
RP + ART + ADT	0.221	0.238	0.238